ACALA-R In Predominantly Demyelinating IgM Mediated Neuropathy
Clinical trial NCT05065554 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05065554
- Sponsor
- Shayna Sarosiek, MD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-16
- Primary completion
- 2026-12-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.